Development Timeline
Underlying Reasons For Pain
Repeated stress to a damaged joint caused by injury or just normal activity can lead to pain and swelling in the joint. This stress can cause damage including fractures to the bone surrounding the injury.
The damage to the bone is largely responsible for the pain. S-Core™ is a platform technology that addresses fractures to the bone and reconstructs the joint. The S-Core™ device has been designed to help reduce the pain and return the joint to its proper bio-mechanical function.
- Full Commercial Lauch
- Surgery being performed in the knee, shoulder, ankle, elbow and great(big) toe.
- Abstracts submitted for peer review publications.
2021
2020
- First Case in Human May 2020
- Post-Operative clinical data collection started
- Q3 – Controlled Market Launch (U.S. Only)
- Q4 – Full Market Launch (U.S. Only)
- Successful MCRA Marketing Regulatory Review
- New FDA Clearance “Minimally Invasive reconstruction of fractures and joints” along with additional size implants Range Now Includes 4mm-10mm
- FDA Clearance for the use of Hydroxyapatite Coating on all size Implants
- Final S-Core™ Device Design, Manufacturing and Regulatory Validations completed
- Thomas Kinder joins company as C.E.O.
- Andy Carter, Phd Biologics joins company as an advisor
2019
2018
- European issues Method and Device for Ameliorating Joint Conditions and Diseases Patent April 2018
- S-Core™ receives 510(k) Clearance September 2017
- Pilot Study completed for the Bioactive S-Core™ Implant System September 2017
- Doctor’s Brian Snyder, Eric Strauss and Marc Safran join the Scientific Advisory Board March 2017
- U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Methods Patent issued January 2017
- Australia issues Method and Device for Ameliorating Joint Conditions and Diseases Patent June 2017
- Series A1 investment round closed
2017
2016
- Japan issues Method and Device for Amerliorating Joint – Conditions and Diseases Patent September 2016
- Steven Arnoczky, DVM joins the Scientific Advisory Board July 2016
- Pilot Study completed for the Bio-mechanical S-Core™ Implant December 2015
- U.S. Methods Patent issued October 2015
- Hong Kong Issues Joint Support and Subchondral Support System Patent July 2015
- Subchondral Solutions completes Series A financing July 2015
- U.S. issues Method and Device for Ameliorating Joint Conditions and Diseases Patent March 2015
2015
2014
- U.S. issues Joint Support and Subchondral Support System – Methods Patent November 2014
- China issues Joint Support and Subchondral Support – System Patent November 2014
- Dr. Nathaniel Cohen joins the Scientific – Advisory Board July 2014
- U.S. issues Joint Support and Subchondral – Support System Patent June 2014
- Co-Founder Thay Lee, PhD Keynote Speaker for the – Athroscopy Association of America’s Annual Meeting May 2014
- John Tighe, CEO of Zipline, joins the Advisory Board
- Subchondral Solutions, Inc. is formed. Co-Founders
- Derek Dee, MD – Chief Medical Officer
- Thay Lee, Phd – Chief Science Officer
- Sheryl McCoy – Chief Financial Officer
- Chris Maurer – Chief Technology Officer
2013
2012
- Singapore issues Joint Support and Subchondral Support System Patent June 2012